References
1. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., Hagen T.M. 16. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem. 2004; 11 (9): 1135-46.
2. Mayr J.A., Feichtinger R.G., Tort F., Ribes A., Sperl W. Lipoic acid biosynthesis defects. J Inherit Metab Dis. 2014; 37 (4): 553-63.
3. Gleiter C.H., Schug B.S., Hermann R., Elze M., Blume H.H., 17. Gundert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol. 1996; 50 (6): 513-4.
4. Suh J.H., Moreau R., Heath S.H., Hagen T.M. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 2005; 10 (1): 52-60.
5. Rooney J.P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology. 2007; 234 (3): 145-56.
6. Zhang J., Zhou X., Wu W., Wang J., Xie H., Wu Z. Regeneration of glutathione by alpha-lipoic acid via Nrf2/ARE signaling pathway alleviates cadmium-induced HepG2 cell toxicity. Environ Toxicol Pharmacol. 2017; 51: 30-7.
7. Fratantonio D., Speciale A., Molonia M.S., et al. Alpha-lipoic acid, but not di-hydrolipoic acid, activates Nrf2 response in primary human umbilical-vein endothelial cells and protects against TNF-alpha induced endothelium dysfunction. Arch Biochem Biophys. 2018; 655: 18-25.
8. Sena C.M., Cipriano M.A., Botelho M.F., Seica R.M. Lipoic acid prevents high-fat diet-induced hepatic steatosis in Goto Kakizaki rats by reducing oxidative stress through Nrf2 activation. Int J Mol Sci. 2018; 19 (9).
9. Fayez A.M., Zakaria S., Moustafa D. Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats. Biomed Pharmacother. 2018; 105: 428-33.
10. Dong Y., Wang H., Chen Z. Alpha-lipoic acid attenuates cerebral ischemia and reperfusion injury via insulin receptor and PI3K/ Akt-dependent inhibition of NADPH oxidase. Int J Endocrinol. 2015; 2015: 903186.
11. Byun E., Lim J.W., Kim J.M., Kim H. alpha-Lipoic acid inhibits Helicobacter pylori-induced oncogene expression and hyperproliferation by suppressing the activation of NADPH oxidase in gastric epithelial cells. Mediators Inflamm. 2014; 2014: 380830.
12. Diesel B., Kulhanek-Heinze S., Holtje M., et al. Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. Biochemistry. 2007; 46 (8): 2146-55.
13. Ying Z., Kampfrath T., Sun Q., Parthasarathy S., Rajagopalan S. Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function. Inflamm Res. 2011; 60 (3): 219-25.
14. Wang Y., Li X., Guo Y., Chan L., Guan X. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism. 2010; 59 (7): 967-76.
15. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol. 2004; 3 (3): 173-89.
16. Akbari M., Ostadmohammadi V., Lankarani K.B., et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018; 87: 56-69.
17. Heinisch B.B., Francesconi M., Mittermayer F., et al. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Eur J Clin Invest. 2010; 40 (2): 148-54.
18. Xiang G., Pu J., Yue L., Hou J., Sun H. alpha-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose. Metabolism. 2011; 60 (4): 480-5.
19. Han T., Bai J., Liu W., Hu Y. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012; 167 (4): 465-71.
20. Ziegler D., Low P.A., Freeman R., Tritschler H., Vinik A.I. Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial. J Diabetes Complications. 2016; 30 (2): 350-6.
21. URL: https://www.rmj.ru/articles/nevrologiya/Mesto_vitaminov_ gruppy_V_i_lipoevoy_kisloty_v_farmakoterapii_polineyropatiy/ (2015)
22. Salinthone S., Schillace R.V., Tsang C., Regan J.W., Bourdette D.N., Carr D.W. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. J Nutr Biochem. 2011; 22 (7): 681-90.
23. Khalili M., Azimi A., Izadi V., et al. Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a doubleblind, placebo-controlled, randomized clinical trial. Neuroimmu-nomodulation. 2014; 21 (6): 291-6.
24. National Multiple Sclerosis Society. Definition of Multiple Sclerosis (MS). URL: https://www.nationalmssociety.org/What-is-MS/ Definition-of-MS. (date of access September 28, 2018)
25. Molz P., Schroder N. Potential therapeutic effects of lipoic acid on memory deficits related to aging and neurodegeneration. Front Pharmacol. 2017; 8: 849.
26. Hager K., Kenklies M., McAfoose J., Engel J., Munch G. Alpha-lipoic acid as a new treatment option for Alzheimer’s disease -a 48 months follow-up analysis. J Neural Transm Suppl. 2007; 72: 189-93.
27. Shinto L., Quinn J., Montine T., et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J. Alzheimers Dis. 2014; 38 (1): 111-20.
28. Namazi N., Larij ani B., Azadbakht L. Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials. Clin Nutr. 2018; 37 (2): 419-28.
29. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009; 1790 (10): 1149-60.
30. Karaarslan U., Isguder R., Bag O., Kisla M., Agin H., Unal N. Alpha lipoic acid intoxication, treatment and outcome. Clin Toxicol (Phila). 2013; 51 (6): 522.